Champions Oncology, Inc.

CSBR · NASDAQ
Analyze with AI
4/30/2025
4/30/2024
4/30/2023
4/30/2022
Assets
Cash & Equivalents$9,785$2,618$10,118$9,007
Short-Term Investments$0$0$0$0
Receivables$11,234$9,526$8,011$9,513
Inventory$0$0$0$0
Other Curr. Assets$1,350$1,495$1,328$1,144
Total Curr. Assets$22,369$13,639$19,457$19,664
Property Plant & Equip (Net)$9,455$11,973$14,504$15,364
Goodwill$335$335$335$335
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$185$185$15$15
Total NC Assets$9,975$12,493$14,854$15,714
Other Assets$0$0$0$0
Total Assets$32,344$26,132$34,311$35,378
Liabilities
Payables$4,248$5,800$5,334$2,868
Short-Term Debt$1,471$1,337$1,208$1,054
Tax Payable$0$0$0$0
Deferred Revenue$15,443$12,094$12,776$11,071
Other Curr. Liab.$2,691$2,310$2,415$2,486
Total Curr. Liab.$23,853$21,541$21,733$17,479
LT Debt$4,634$6,093$7,391$8,412
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$85$401$551$391
Total NC Liab.$4,719$6,494$7,942$8,803
Other Liabilities$0$0$0$0
Cap. Leases$6,105$7,430$8,599$9,466
Total Liabilities$28,572$28,035$29,675$26,282
Equity
Pref Stock$0$0$0$0
Common Stock$14$14$14$14
Retained Earnings-$79,892-$84,593-$77,317-$71,982
AOCI$0$0$0$0
Other Equity$83,650$82,676$81,939$81,064
Total Equity$3,772-$1,903$4,636$9,096
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$32,344$26,132$34,311$35,378
Net Debt-$3,680$4,812-$1,519$459